p53-Mediated Inhibition of Angiogenesis Through Up-Regulation of a Collagen Prolyl Hydroxylase

Recent evidence suggests that antiangiogenic therapy is sensitive to p53 status in tumors, implicating a role for p53 in the regulation of angiogenesis. Here we show that p53 transcriptionally activates the α(II) collagen prolyl-4-hydroxylase [α(II)PH] gene, resulting in the extracellular release of antiangiogenic fragments of collagen type 4 and 18. Conditioned media from cells ectopically expressing either p53 or α(II)PH selectively inhibited growth of primary human endothelial cells. When expressed intracellularly or exogenously delivered, α(II)PH significantly inhibited tumor growth in mice. Our results reveal a genetic and biochemical linkage between the p53 tumor suppressor pathway and the synthesis of antiangiogenic collagen fragments.

[1]  R. Kalluri,et al.  Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Kahn,et al.  Tumstatin, an Endothelial Cell-Specific Inhibitor of Protein Synthesis , 2002, Science.

[3]  B. Olsen,et al.  The role of collagen-derived proteolytic fragments in angiogenesis. , 2001, Matrix biology : journal of the International Society for Matrix Biology.

[4]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[5]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[6]  L. Ellis,et al.  Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. , 2000, Cancer research.

[7]  G. Semenza,et al.  Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. , 2000, Genes & development.

[8]  T. Pihlajaniemi,et al.  Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[9]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[10]  Thierry Soussi,et al.  Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects , 1997, Nucleic Acids Res..

[11]  N. Gotelli,et al.  NULL MODELS IN ECOLOGY , 1996 .

[12]  K. Dameron,et al.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.

[13]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[14]  Jessica Gurevitch,et al.  Design and Analysis of Ecological Experiments , 1993 .

[15]  K. Kivirikko,et al.  Posttranslational enzymes in the biosynthesis of collagen: intracellular enzymes. , 1982, Methods in enzymology.

[16]  I. Fidler.  Biological behavior of malignant melanoma cells correlated to their survival in vivo. , 1975, Cancer research.